의료 IoT 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of Internet of Medical Things (IoMT) Market

The global Internet of Medical Things (IoMT) market is undergoing exponential growth, driven by rapid digital transformation in healthcare, increasing adoption of remote patient monitoring systems, and rising demand for connected medical devices. IoMT refers to a network of medical devices, sensors, and software applications connected via the internet to collect and exchange patient health data in real time, enabling remote diagnosis, monitoring, and treatment.

Market Size and Forecast

The global IoMT market was valued at USD 77.49 billion in 2025. It is projected to grow significantly to USD 101.89 billion in 2026, and further surge to USD 1,906.70 billion by 2034, registering a CAGR of 44.22% during 2026-2034.

This exceptional growth reflects rapid digitalization of healthcare systems and increasing reliance on connected medical technologies worldwide.

Market Overview

IoMT integrates smart medical devices, cloud platforms, and healthcare IT systems to enable continuous patient monitoring and efficient healthcare delivery. These technologies eliminate the need for manual intervention in data collection and improve decision-making for doctors and healthcare providers.

The market gained strong momentum during the COVID-19 pandemic, as telemedicine and remote monitoring became essential healthcare solutions.

Key Market Trends

A major trend in the IoMT market is the rapid expansion of telehealth and remote patient monitoring systems, supported by advancements in 4G, 5G, and cloud computing technologies.

Companies such as Philips and Medtronic are actively developing connected healthcare devices integrated with AI and cloud analytics.

Another key trend is the rising adoption of wearable medical devices, such as smartwatches and biosensors, which enable continuous tracking of vital health parameters in real time.

Market Growth Drivers

The IoMT market is primarily driven by:

• Increasing demand for remote patient monitoring
• Rising prevalence of chronic diseases
• Growth in telemedicine and virtual healthcare services
• Expansion of healthcare IT infrastructure
• Government support for digital health transformation

According to industry estimates, healthcare IoT investments are expected to grow significantly as hospitals adopt connected ecosystems for improved patient care and cost reduction.

Market Restraints

Despite rapid growth, the market faces several challenges:

• High risk of cyberattacks and data breaches
• Lack of standardized security protocols for medical devices
• Network reliability issues in remote areas
• Concerns regarding patient data privacy

More than 60% of medical devices are reported to be vulnerable to cybersecurity threats, which limits widespread adoption in some regions.

Segmentation Analysis

By Product

The stationary medical devices segment dominates the market, supported by hospital infrastructure modernization and government investments in digital healthcare systems.

The wearable medical devices segment is expected to grow at the fastest rate due to increasing consumer adoption of health tracking devices.

By Application

The telemedicine segment holds the largest market share with 33.97% in 2026, driven by increasing demand for virtual consultations and remote diagnosis.

The patient monitoring segment is expected to grow rapidly due to rising chronic disease cases and the need for continuous health tracking.

By End User

The healthcare providers segment dominates the market with 33.30% share in 2026, as hospitals and clinics increasingly rely on IoMT solutions for patient care.

Government agencies are also expanding adoption for public health monitoring and healthcare system optimization.

Regional Insights

North America

North America leads the IoMT market with USD 22.46 billion in 2025 and USD 28.80 billion in 2026, supported by strong healthcare infrastructure and early adoption of digital health technologies. The U.S. market is projected to reach USD 167.04 billion by 2032.

Europe

Europe is the second-largest market, driven by government funding programs like Horizon 2020 and strong adoption of digital healthcare systems in countries such as Germany and the U.K.

Asia Pacific

Asia Pacific is the fastest-growing region due to rising healthcare spending, expanding telemedicine services, and government initiatives in China, India, and Japan.

Latin America & Middle East & Africa

These regions are witnessing gradual adoption of IoMT technologies due to improving healthcare infrastructure and growing awareness of digital health solutions.

Competitive Landscape

The IoMT market is highly competitive and includes global technology and healthcare leaders focused on innovation, partnerships, and acquisitions. Key companies include GE Healthcare, Siemens Healthineers, Cisco, and IBM.

These companies are heavily investing in AI-powered healthcare platforms, connected devices, and cybersecurity solutions to strengthen their market position.

Conclusion

The global IoMT market is expected to experience explosive growth, rising from USD 77.49 billion in 2025 to USD 1,906.70 billion by 2034, driven by technological advancements, increasing demand for remote healthcare, and rapid digital transformation in the medical sector. Despite cybersecurity challenges, IoMT is set to become a foundational pillar of modern healthcare systems, enabling smarter, faster, and more efficient patient care worldwide.

Segmentation By Product

• Stationary Medical Devices
• Implanted Medical Devices
• Wearable External Medical Devices

By Application

• Telemedicine
• Medication Management
• Patient Monitoring
• Others

By End-user

• Healthcare Providers
• Patients
• Government Authorities
• Others

By Geography

• North America (By Product, Application, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product, Application, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, Application, End-user, and Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, Application, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, Application, End-user, and Country/Sub-region)
  • GCC
  • South Africa
• Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview: Start-ups Funding
• 4.2. Technological Advancements in IoMT Devices
• 4.3. Snapshot by Ways the IoMT Impacts Healthcare
• 4.4. Overview: New Application Areas
• 4.5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.6. New Product Launches, By Key Players
• 4.7. Impact of COVID-19 on Global IoMT Market
• 4.8. Key Trends Accelerated by COVID-19

5. Global Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Stationary Medical Devices
  • 5.1.2. Implanted Medical Devices
  • 5.1.3. Wearable External Medical Devices
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Telemedicine
  • 5.2.2. Medication Management
  • 5.2.3. Patient Monitoring
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Healthcare Providers
  • 5.3.2. Patients
  • 5.3.3. Government Authorities
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Geography
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Stationary Medical Devices
  • 6.1.2. Implanted Medical Devices
  • 6.1.3. Wearable External Medical Devices
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Telemedicine
  • 6.2.2. Medication Management
  • 6.2.3. Patient Monitoring
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Healthcare Providers
  • 6.3.2. Patients
  • 6.3.3. Government Authorities
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Stationary Medical Devices
  • 7.1.2. Implanted Medical Devices
  • 7.1.3. Wearable External Medical Devices
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Telemedicine
  • 7.2.2. Medication Management
  • 7.2.3. Patient Monitoring
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Healthcare Providers
  • 7.3.2. Patients
  • 7.3.3. Government Authorities
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Stationary Medical Devices
  • 8.1.2. Implanted Medical Devices
  • 8.1.3. Wearable External Medical Devices
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Telemedicine
  • 8.2.2. Medication Management
  • 8.2.3. Patient Monitoring
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Healthcare Providers
  • 8.3.2. Patients
  • 8.3.3. Government Authorities
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. Japan
  • 8.4.2. Australia
  • 8.4.3. China
  • 8.4.4. India
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of APAC

9. Latin America Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Stationary Medical Devices
  • 9.1.2. Implanted Medical Devices
  • 9.1.3. Wearable External Medical Devices
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Telemedicine
  • 9.2.2. Medication Management
  • 9.2.3. Patient Monitoring
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Healthcare Providers
  • 9.3.2. Patients
  • 9.3.3. Government Authorities
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Internet of Medical Things (IoMT) Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Stationary Medical Devices
  • 10.1.2. Implanted Medical Devices
  • 10.1.3. Wearable External Medical Devices
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Telemedicine
  • 10.2.2. Medication Management
  • 10.2.3. Patient Monitoring
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Healthcare Providers
  • 10.3.2. Patients
  • 10.3.3. Government Authorities
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Boston Scientific Corporation
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. General Electric Company
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Johnson & Johnson Services, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Medtronic
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Koninklijke Philips N.V.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Siemens Healthineers AG
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Cisco
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. IBM
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Baxter (Hill-Rom Services, Inc.)
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. BIOTRONIK
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)